Neurophyxia is an innovative clinical drug development company developing novel drugs to reduce the deleterious effects of oxygen shortage in the brain. Our lead product 2-IB is currently in Phase II Clinical Trials for 3 indications:
- Stroke in adults
- Cardiac Arrest in adults
- Birth Asphyxia in newborns.